(Bloomberg) — About half of Covid-19 hospital patients experienced at least one symptom 12 months later, according to a study in the medical journal The Lancet, which tracked patients in Wuhan. Nearly one in three suffered from shortness of breath, while about one in five had fatigue and muscle weakness.
Malaysia is now Southeast Asia’s Covid-19 hotspot, reporting a record 24,599 new cases on Thursday, eclipsing Indonesia and Thailand where daily infections have ebbed. The outbreak is set to prolong the global chip shortage as the country is a key center for semiconductor testing and packaging.
In the U.S., the delta-fueled spread worsened, as Texas deployed another 2,500 medical staff and equipment to health care facilities throughout the state as hospitalizations near a record. Illinois issued broader measures to contain the spread, mandating masks indoors statewide and expanding vaccine requirements.
Key Developments:
- Global Tracker: Cases top 214.4 million; deaths pass 4.47 million
- Vaccine Tracker: More than 5.11 billion doses administered
- Most big hedge funds mandate vaccinations for return to offices
- Are Covid shots working? What the real world tells us: QuickTake
- The hybrid work revolution is already transforming economies
- September promised return to normal that continues to elude U.S.
Malaysia’s Outbreak Outpaces Rest of Southeast Asia (7:40 a.m. HK)
Malaysia is now Southeast Asia’s Covid-19 hotspot, reporting a record 24,599 new cases on Thursday, eclipsing Indonesia and Thailand where daily infections have ebbed. The surge, driven by the highly contagious delta variant, poses a risk to Malaysia’s recovery, with the central bank recently lowering its economic growth forecast for the year, and threatens to prolong the chip shortage with the country a key center for semiconductor testing and packaging.
Blood Clot Risk Much Higher From Covid Than Vaccines (7:20 a.m. HK)
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.’s shots, according to a large U.K. study.
For every 10 million people who receive the first dose of AstraZeneca, about 66 more will suffer from a blood-clotting syndrome than during normal circumstances, according to the study published in the British Medical Journal. This figure compares with 12,614 more incidences recorded in 10 million people who have tested positive for Covid-19.
The study followed 29 million people who received their first doses of either AstraZeneca or Pfizer vaccine between December and April, and also tracked about 1.7 million Covid-19 patients.
Covid Complications Linger, Study Finds (6:30 p.m. NY)
About half of Covid-19 hospital patients experienced at least one symptom 12 months later, according to a large study published in the medical journal The Lancet.
Nearly one in three patients suffered from shortness of breath, while about one in five patients said they still experienced fatigue and muscle weakness, researchers found. The study following 1,276 patients discharged from a hospital in Wuhan, China, between January and May last year also found that women were twice as likely to deal with lung dysfunction compared to men.
The evidence that some patients will take longer than one year to recover “should be taken into account when planning delivery of health-care services post-pandemic,” said Bin Cao, a professor from the National Center for Respiratory Medicine, China-Japan Friendship Hospital. A previous study of 1,733 Covid-19 survivors after six months, by the same researchers, found that around three-quarters had persistent health problems.
Anthem Requires Vaccines for Return to Office (4:03 p.m. NY)
Anthem Inc. is requiring employees to be vaccinated before returning to offices. The health insurer announced the requirement to staff internally earlier this month, a spokeswoman confirmed to Bloomberg News. The requirement also applies to workers who have patient- or customer-facing jobs. Most Anthem offices in the U.S. remain closed.
UAW Won’t Push to Mandate Vaccines (3:55 p.m. NY)
The United Autos Workers, the largest U.S. auto union, doesn’t plan to push its members beyond voluntarily taking a Covid-19 vaccine, barring a national mandate, President Ray Curry told reporters in a call on Thursday.
The UAW is open to having discussions with employers about vaccine mandates and voluntary disclosure of vaccine records, but the ultimate goal is that “we would respect the wishes of our membership,” Curry said.
Arkansas Inmates Prescribed Anti-Parasite Drug (3:10 p.m. NY)
Arkansas health officials are investigating reports that a county jail prescribed to inmates an anti-parasite drug often used for livestock, the Associated Press reported.
Amy Embry, director of the Arkansas Medical Board, said the investigation opened two days ago but declined to give details. The sheriff of Washington County confirmed on Tuesday that inmates had been prescribed ivermectin, AP reported. The U.S. Food and Drug Administration has warned against using the drug, which is approved in lower doses to treat two conditions in humans caused by parasitic worms, to prevent or treat Covid-19.
Texas Deploys More Help to Hospitals (2:55 p.m. NY)
Texas Governor Greg Abbott deployed another 2,500 medical staff and equipment to health care facilities throughout the state as the hospitalization rate nears a record set in January.
The Lone Star state had 13,928 hospitalized patients on Tuesday, close to the record 14,218 set on Jan. 11, before vaccinations became more widespread. Almost half of the state’s trauma service areas had fewer than five beds available in intensive care units, with four areas having run out of them altogether.
The new deployment brings the total number of additional, state-funded medical personnel to 8,100.
U.K. to Study Why Breakthrough Cases Happen (1:30 p.m. NY)
The newly-formed U.K. Health Security Agency will lead a study into why some vaccinated people get breakthrough infections and others don’t.
The study involves about 50,000 staffers in the National Health Service who enrolled in other Covid-related studies under which they get PCR tests every two weeks and regular antibody tests. Antibody results of those who test positive for Covid-19 despite having two vaccine doses or a previous confirmed infection will be analyzed for how their immune response differs from those who don’t contract the virus.
Understanding the immune response will help “vaccine developers who can target key components of the immune response effectively for future booster vaccines,” said Susan Hopkins, Public Health England’s Covid response director.
Illinois Mandates Masks (11:55 a.m. NY)
Illinois Governor J.B. Pritzker, a Democrat, issued a statewide indoor mask mandate starting Monday and expanded vaccine requirements, saying “we are running out of time as our hospitals run out of beds.”
Pritzker’s administration required this month that employees at state-run congregate facilities be vaccinated. That mandate now expands to all health-care workers, including those in public and private nursing homes; teachers and staff at Pre-K through 12th grade schools; and personnel and students at higher education institutions.
Covered individuals must receive their first dose by Sept. 5 or be subject to regular testing. The shrinking hospital-bed capacity is mostly due to tight staffing, rather than space constraints, Pritzker told a news conference.
Kentucky, Florida Lead in U.S. Hospital Admissions (11:20 a.m. NY)
Kentucky, Florida and Georgia led U.S. states in per-capita hospital admissions for Covid-19 during the week that ended Monday, according to a Centers for Disease Control and Prevention update published Thursday.
Florida had the most admissions during the period with almost 15,100 new patients, reflecting the strain of the delta variant on health care. The per-capita number varies widely, from 31.1 per 100,000 residents in Kentucky to a low of 2.2 in Vermont.
The CDC reported 5,665 U.S. deaths during the week through Tuesday, a 23% increase compared to the previous seven-day period.
Pfizer Taps Brazil Producer (11:04 a.m. NY)
Pfizer Inc. and BioNTech SE announced a deal with a Brazilian manufacturer to produce 100 million doses of their vaccine annually for Latin America.
Under the terms announced Thursday, the Brazilian pharmaceutical company Eurofarma Laboratorios SA will perform the so-called fill-and-finish process in which the vaccine is put into sterile vials. Eurofarma will begin manufacturing finished doses at its facility in Sao Paulo in 2022.
India Cases Reach One-Month High (2:33 p.m. HK)
India recorded 46,164 new cases Thursday, the most for a single day in more than a month. Kerala reported a surge in infections that could threaten the state’s economy, which had held steady in July as cases declined.
The total tally now stands at 32.6 million. Almost 604 million vaccine doses have been administered so far but only 9.6% of India’s population is fully inoculated against the virus, according to Bloomberg’s vaccine tracker. Covid-related deaths rose by 607 in a day to 436,365, as per the latest health ministry data.
Israel Cases at Record Despite Vaccinations (11:37 a.m. HK)
Israel, one of the most vaccinated countries in the world, posted record new infections.
Israel was the first to approve booster doses in late July. That followed an early, aggressive approach to immunizing its people. More than 72% of the population is covered using the most effective mRNA shots available.
More stories like this are available on bloomberg.com
©2021 Bloomberg L.P.
